Mingmei Cai

606 total citations
15 papers, 456 citations indexed

About

Mingmei Cai is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mingmei Cai has authored 15 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Mingmei Cai's work include Cancer Immunotherapy and Biomarkers (5 papers), interferon and immune responses (2 papers) and Cancer Research and Treatments (2 papers). Mingmei Cai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), interferon and immune responses (2 papers) and Cancer Research and Treatments (2 papers). Mingmei Cai collaborates with scholars based in United States and China. Mingmei Cai's co-authors include Elaine M. Pinheiro, Chunsheng Zhang, Anandi Sawant, Dewan Md Sakib Hossain, Manjiri Sathe, Jeff Grein, Wendy M. Blumenschein, Alissa A. Chackerian, Sarah Javaid and Weikang Tao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Mingmei Cai

13 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingmei Cai United States	8	253	182	135	51	40	15	456
Pin‐Ji Lei United States	12	314 1.2×	138 0.8×	94 0.7×	56 1.1×	82 2.0×	24	508
Giulia Chiaruttini United Kingdom	7	188 0.7×	166 0.9×	203 1.5×	33 0.6×	68 1.7×	10	446
Sonia Iyer United States	12	282 1.1×	121 0.7×	155 1.1×	22 0.4×	65 1.6×	23	483
Louise M.E. Janssen Netherlands	5	139 0.5×	180 1.0×	144 1.1×	68 1.3×	53 1.3×	5	412
Xiangyi Shi China	10	164 0.6×	70 0.4×	156 1.2×	38 0.7×	49 1.2×	15	407
Felipe Vences‐Catalán United States	12	228 0.9×	110 0.6×	235 1.7×	20 0.4×	55 1.4×	17	505
Stephen H. Kazakoff Australia	12	193 0.8×	172 0.9×	117 0.9×	55 1.1×	72 1.8×	18	441
Gerald Moncayo Switzerland	10	321 1.3×	76 0.4×	131 1.0×	62 1.2×	76 1.9×	12	532
Hyun-Jung Kim South Korea	9	177 0.7×	101 0.6×	75 0.6×	37 0.7×	53 1.3×	12	342
María Alejandra Gleisner Chile	15	298 1.2×	212 1.2×	310 2.3×	30 0.6×	44 1.1×	24	620

Countries citing papers authored by Mingmei Cai

Since Specialization

Citations

This map shows the geographic impact of Mingmei Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingmei Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingmei Cai more than expected).

Fields of papers citing papers by Mingmei Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingmei Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingmei Cai. The network helps show where Mingmei Cai may publish in the future.

Co-authorship network of co-authors of Mingmei Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Mingmei Cai. A scholar is included among the top collaborators of Mingmei Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingmei Cai. Mingmei Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nayak, Tapan K., Li Li, Sophie H. Li, et al.. (2025). Abstract 4364: Preclinical pharmacokinetics and pharmacodynamics of MK-4464, a novel NK cell engager targeting CEACAM5. Cancer Research. 85(8_Supplement_1). 4364–4364.

Xu, Jun, Nicolas Solban, Yun Wang, et al.. (2021). Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression (Adv. Therap. 10/2021). Advanced Therapeutics. 4(10). 1 indexed citations

Xu, Jun, Nicolas Solban, Yun Wang, et al.. (2021). Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression. Advanced Therapeutics. 4(10). 4 indexed citations

Han, Jin‐Hwan, Mingmei Cai, Samanthi A. Perera, et al.. (2020). Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation. Frontiers in Immunology. 11. 573405–573405. 27 indexed citations

Hossain, Dewan Md Sakib, Sarah Javaid, Mingmei Cai, et al.. (2018). Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression. Journal of Clinical Investigation. 128(2). 644–654. 167 indexed citations

Pinheiro, Elaine M., Ruban Mangadu, Mingmei Cai, et al.. (2016). Abstract 543: Preclinical combination strategies to enhance the efficacy of the anti-PD-1 antibody pembrolizumab. Cancer Research. 76(14_Supplement). 543–543.

Ugarte, Fernando, Anandi Sawant, Mingmei Cai, et al.. (2016). Abstract 562: Dinaciclib induces immunogenic cell death and enhances anti-PD-1 mediated tumor suppression. Cancer Research. 76(14_Supplement). 562–562. 1 indexed citations

Pinheiro, Elaine M., Ruban Mangadu, Uyen Phan, et al.. (2015). Abstract 269: Evaluation of the antitumor activity of anti-PD-1 immunotherapy as a single agent and in combination with approved agents in preclinical tumor models. Cancer Research. 75(15_Supplement). 269–269. 1 indexed citations

Hirsch, Heather A., Elaine M. Pinheiro, Mingmei Cai, et al.. (2015). Abstract 1328: Molecular characterization of mouse syngeneic tumor models in response to treatment with anti-PD-1 immunotherapy. Cancer Research. 75(15_Supplement). 1328–1328. 1 indexed citations

10.

Tao, Weikang, Xianzhi Mao, Joseph P. Davide, et al.. (2010). Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses. Molecular Therapy. 19(3). 567–575. 57 indexed citations

11.

Tao, Weikang, Joseph P. Davide, Mingmei Cai, et al.. (2010). Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the Liver. Molecular Therapy. 18(9). 1657–1666. 40 indexed citations

12.

Cai, Mingmei, Manickam Sugumaran, & William E. Robinson. (2008). The crosslinking and antimicrobial properties of tunichrome. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 151(1). 110–117. 34 indexed citations

13.

Chen, She, Xianglei Yin, Xiaoyu Zhu, et al.. (2003). The C-terminal Kinase Domain of the p34cdc2-related PITSLRE Protein Kinase (p110C) Associates with p21-activated Kinase 1 and Inhibits Its Activity during Anoikis. Journal of Biological Chemistry. 278(22). 20029–20036. 39 indexed citations

14.

Zhang, Si, et al.. (2003). Involvement of β 1,4 galactosyltransferase 1 and Galβ 1→4GlcNAc groups in human hepatocarcinoma cell apoptosis. Molecular and Cellular Biochemistry. 243(1-2). 81–86. 12 indexed citations

15.

Zhang, Songwen, Mingmei Cai, Si Zhang, et al.. (2002). Interaction of p58PITSLRE, a G2/M-specific Protein Kinase, with Cyclin D3. Journal of Biological Chemistry. 277(38). 35314–35322. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact